首页> 外文期刊>Toxicology and Applied Pharmacology >4-Hydroxy-2-nonenal enhances fibronectin production by IMR-90 human lung fibroblasts partly via activation of epidermal growth factor receptor-linked extracellular signal-regulated kinase p44/42 pathway.
【24h】

4-Hydroxy-2-nonenal enhances fibronectin production by IMR-90 human lung fibroblasts partly via activation of epidermal growth factor receptor-linked extracellular signal-regulated kinase p44/42 pathway.

机译:4-羟基-2-壬烯醛部分地通过激活表皮生长因子受体相关的细胞外信号调节激酶p44 / 42途径来增强IMR-90人肺成纤维细胞的纤连蛋白生成。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

To elucidate the underlying mechanisms in oxidative stress-related airway remodeling observed in chronic inflammatory pulmonary diseases such as asthma, we studied the effects of a thiol antioxidant, N-acetylcysteine (NAC), a selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, AG-1478, and tyrphostin-1 as a negative control for AG-1478 on an aldehydic product of lipid peroxidation 4-hydroxy-2-nonenal (HNE)-induced secretion of fibronectin by IMR-90 human lung fibroblasts. We also studied signal transduction pathways involved in the secretion of fibronectin evident after exposure of IMR-90 cells to HNE. Twenty-five-micromole HNE treatments of IMR-90 cells activated extracellular signal-regulated kinase p44/42 (Erk1/2) with little activation of p38 mitogen-activated protein kinase (p38MAPK) and no activation of c-Jun NH(2)-terminal kinase. HNE-induced secretion of fibronectin was inhibited by U-0126, an inhibitor of the Erk1/2 pathway, while no significant inhibition by SB-203580, an inhibitor of p38MAPK pathway, was observed. NAC and AG-1478, but not tyrphostin-1, inhibited HNE-induced fibronectin secretion accompanied by a pallarel inhibition of Erk1/2 activation. These data suggest that pulmonary oxidative stress-related lipid peroxidation may play an important role in developing airway remodeling through activating lung fibroblasts to further produce extracellular matrices, such as fibronectin, partly via activation of an EGFR-linked Erk1/2 signal transduction pathway, and that the antioxidant NAC and the EGFR tyrosine kinase inhibitor AG-1478 can be potentially useful in pulmonary diseases involving airway remodeling.
机译:为了阐明在慢性炎症性肺病(例如哮喘)中观察到的氧化应激相关气道重塑的潜在机制,我们研究了硫醇抗氧化剂N-乙酰半胱氨酸(NAC),选择性表皮生长因子受体(EGFR)酪氨酸激酶抑制剂的作用,AG-1478和tyrphostin-1作为AG-1478对IMR-90人肺成纤维细胞脂质过氧化4-羟基-2-壬烯醛(HNE)诱导的纤连蛋白分泌的醛类产物的阴性对照。我们还研究了IMR-90细胞暴露于HNE后明显参与纤连蛋白分泌的信号转导途径。对IMR-90细胞进行25微摩尔HNE处理可激活细胞外信号调节激酶p44 / 42(Erk1 / 2),而对p38丝裂原活化蛋白激酶(p38MAPK)的激活很少,对c-Jun NH也没有激活(2) -末端激酶。 HNE诱导的纤连蛋白分泌被Erk1 / 2途径的抑制剂U-0126抑制,而未观察到p38MAPK途径的抑制剂SB-203580的显着抑制。 NAC和AG-1478(但不是tyrphostin-1)抑制HNE诱导的纤连蛋白分泌,同时伴有pallarel抑制Erk1 / 2激活。这些数据表明,与肺氧化应激相关的脂质过氧化可能通过激活肺成纤维细胞以进一步产生细胞外基质(例如纤连蛋白)而在气道重塑中发挥重要作用,部分是通过激活EGFR连接的Erk1 / 2信号转导通路来实现的,以及抗氧化剂NAC和EGFR酪氨酸激酶抑制剂AG-1478可能在涉及气道重塑的肺部疾病中可能有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号